9526 Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Form name Type of 

respondent 

Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total 

annual 

burden 

hours 

Study Closure or Transfer of Study Review Responsibility (Attachment B43).Health Care Practitioner 1,680 1 15/60 420 

Unanticipated Problem or Serious or Continuing 

Noncompliance Reporting Form (Attachment 

B44).

Health Care Practitioner 360 1 20/60 120 

Change of Signatory Institution PI Form (Attachment B45).Health Care Practitioner 120 1 20/60 40 

Request Waiver of Assent Form (Attachment 

B46).

Health Care Practitioner 35 1 20/60 12 

CIRB Waiver of Consent Request Supplemental 

Form (Attachment B47).

Health Care Practitioner 20 1 15/60 5 

Review Worksheet CIRB Review for Inclusion of 

Incarcerated Participants (Attachment B48).

Board Members ............ 20 1 60/60 20 

Notification of Incarcerated Participant Form 

(B49).

Health Care Practitioner 20 1 20/60 7 

CTSU OPEN Survey (Attachment C03) ............... Health Care Practitioner 10 1 15/60 3 

CIRB Customer Satisfaction Survey (Attachment 

C04).

Participants ................... 600 1 15/60 150 

Follow-up Survey (Communication Audit) (Attachment C05).Participants/Board 

Members.

300 1 15/60 75 

CIRB Board Member Annual Assessment Survey 

(Attachment C07).

Board Members ............ 60 1 15/60 15 

PIO Customer Satisfaction Survey (Attachment 

C08).

Health Care Practitioner 60 1 5/60 5 

Audit Scheduling Form (Attachment D01) ............ Health Care Practitioner 152 5 21/60 266 

Preliminary Audit Finding Form (Attachment D02) Health Care Practitioner 152 5 10/60 127 

Audit Maintenance Form (Attachment D03) ......... Health Care Practitioner 152 5 9/60 114 

Final Audit finding Report Form (Attachment 

D04).

Health Care Practitioner 75 11 1,098/60 15,098 

Follow-up Form (Attachment D05) ....................... Health Care Practitioner 75 7 27/60 236 

Roster Maintenance Form (Attachment D06) ...... Health Care Practitioner 5 1 18/60 2 

Final Report and CAPA Request Form (Attachment D07).Health Care Practitioner 12 9 1,800/60 3,240 

NCI/DCTD/CTEP FDA Form 1572 for Annual 

Submission (Attachment E01).

Physician ...................... 26,500 1 15/60 6,625 

NCI/DCTD/CTE Biosketch (Attachment E02) ...... Physician; Health Care 

Practitioner.

48,000 1 120/60 96,000 

NCI/DCTD/CTEP Financial Disclosure Form (Attachment E03).Physician; Health Care 

Practitioner.

48,000 1 15/60 12,000 

NCI/DCTD/CTEP Agent Shipment Form (ASF) 

(Attachment E04).

Physician ...................... 24,000 1 10/60 4,000 

Totals ............................................................. ....................................... 167,715 235,670 ........................ 151,792 

Dated: February 1, 2021. 

Diane Kreinbrink, 

Project Clearance Liaison, National Cancer 

Institute, National Institutes of Health. 

[FR Doc. 2021–03046 Filed 2–12–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Prevention’s 

(CSAP) Drug Testing Advisory Board 

(DTAB) will convene via web 

conference on March 2nd, 2021, from 

10:00 a.m. EST to 4:30 p.m. EST, and 

March 3rd, 2021, from 10:00 a.m. EST 

to 4:30 p.m. EST. 

The board will meet in open-session 

March 2nd, 2021, from 10:00 a.m. EST 

to 2:00 p.m. EST to discuss the 

Mandatory Guidelines for Federal 

Workplace Drug Testing Programs with 

updates from the Department of 

Transportation, the Nuclear Regulatory 

Commission, and the Department of 

Defense. Other discussion topics 

include an update on marijuana studies 

and efforts as well as the Employee 

Assistance Program (EAP) Toolkit. The 

board will meet in closed-session on 

March 2nd, 2021, from 2:15 p.m. EST to 

4:30 p.m. EST, and March 3rd, 2021, 

from 10:00 a.m. EST to 4:30 p.m. EST, 

to discuss confidential issues 

surrounding the proposed Mandatory 

Guidelines for Federal Workplace Drug 

Testing Programs (hair), the Federal 

Drug-Free Workplace Programs and 

emerging issues, updates on the 

revisions of the Urine and Oral Fluid 

Mandatory Guidelines and the 

Biomarker Table, preliminary and 

unpublished studies from the Johns 

Hopkins University Behavioral 

Pharmacology Research Unit (BPRU), 

and cannabidiol (CBD) information from 

FDA. Therefore, the March 2nd, 2021, 

from 2:15 p.m. EST to 4:30 p.m. EST, 

and the March 3rd, 2021, from 10:00 

a.m. EST to 4:30 p.m. EST, meetings are 

closed to the public, as determined by 

the Assistant Secretary for Mental 

Health and Substance Use, SAMHSA, in 

accordance with 5 U.S.C. 552b(c)(4) and 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 29 / Tuesday, February 16, 2021 / Notices 9527 

(9)(B), and 5 U.S.C. App. 2, Section 

10(d). 

Meeting registration can be completed 

at http://snacregister.samhsa.gov/ 

MeetingList.aspx. Web conference and 

call information will be sent after 

completing registration. Meeting 

information and a roster of DTAB 

members may be obtained by accessing 

the SAMHSA Advisory Committees 

website, https://www.samhsa.gov/ 

about-us/advisory-councils/meetings or 

by contacting the Designated Federal 

Officer, Jennifer Fan. 

Committee Name: Substance Abuse 

and Mental Health Services 

Administration, Center for Substance 

Abuse Prevention, Drug Testing 

Advisory Board. 

Dates/Time/Type: March 2, 2021, 

from 10:00 a.m. to 2:00 p.m. EST: OPEN, 

March 2, 2021, from 2:15 p.m. to 4:30 

p.m. EST: CLOSED, March 3, 2021, from 

10:00 a.m. to 4:30 p.m. EST: CLOSED. 

Place: Substance Abuse and Mental 

Health Services Administration, 5600 

Fishers Lane, Rockville, MD 20857. 

Contact: Jennifer Fan, Senior 

Pharmacist, Center for Substance Abuse 

Prevention, 5600 Fishers Lane, Room 

16N06D, Rockville, Maryland 20857, 

Telephone: (240) 276–1759, Email: 

jennifer.fan@samhsa.hhs.gov. 

Note: For technical reasons, SAMHSA was 

unable to provide the normal 15-day advance 

noticification of the meeting. 

Anastasia Marie Donovan, 

Policy Anayst. 

[FR Doc. 2021–03065 Filed 2–12–21; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

[1651–0136] 

Generic Clearance for the Collection of 

Qualitative Feedback on Agency 

Service Delivery 

AGENCY: U.S. Customs and Border 

Protection (CBP), Department of 

Homeland Security. 

ACTION: 30-Day notice and request for 

comments; extension of an existing 

collection of information. 

SUMMARY: The Department of Homeland 

Security, U.S. Customs and Border 

Protection will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995 (PRA). The 

information collection is published in 

the Federal Register to obtain comments 

from the public and affected agencies. 

DATES: Comments are encouraged and 

must be submitted (no later than March 

18, 2021 to be assured of consideration. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional PRA information 

should be directed to Seth Renkema, 

Chief, Economic Impact Analysis 

Branch, U.S. Customs and Border 

Protection, Office of Trade, Regulations 

and Rulings, 90 K Street NE, 10th Floor, 

Washington, DC 20229–1177, 

Telephone number 202–325–0056 or via 

email CBP_PRA@cbp.dhs.gov. Please 

note that the contact information 

provided here is solely for questions 

regarding this notice. Individuals 

seeking information about other CBP 

programs should contact the CBP 

National Customer Service Center at 

877–227–5511, (TTY) 1–800–877–8339, 

or CBP website at https://www.cbp.gov/. 

SUPPLEMENTARY INFORMATION: CBP 

invites the general public and other 

Federal agencies to comment on the 

proposed and/or continuing information 

collections pursuant to the Paperwork 

Reduction Act of 1995 (44 U.S.C. 3501 

et seq.). This proposed information 

collection was previously published in 

the Federal Register (85 FR 75347) on 

November 25, 2020, allowing for a 60- 

day comment period. This notice allows 

for an additional 30 days for public 

comments. This process is conducted in 

accordance with 5 CFR 1320.8. Written 

comments and suggestions from the 

public and affected agencies should 

address one or more of the following 

four points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; (2) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

suggestions to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) suggestions to 

minimize the burden of the collection of 

information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology, e.g., permitting 

electronic submission of responses. The 

comments that are submitted will be 

summarized and included in the request 

for approval. All comments will become 

a matter of public record. 

Overview of This Information 

Collection 

Title: Generic Clearance for the 

Collection of Qualitative Feedback on 

Agency Service Delivery. 

OMB Number: 1651–0136. 

Current Actions: This submission is 

being made to extend the expiration 

date with no change to the burden 

hours. 

Type of Review: Extension (without 

change). 

Affected Public: Individuals and 

businesses. 

Abstract: Executive Order 12862 

directs Federal agencies to provide 

service to the public that matches or 

exceeds the best service available in the 

private sector. In order to work 

continuously to ensure that our 

programs are effective and meet our 

customers’ needs, U.S. Customs and 

Border Protection (CBP) (hereafter ‘‘the 

Agency’’) seeks to obtain OMB approval 

of a generic clearance to collect 

qualitative feedback on our service 

delivery. By qualitative feedback we 

mean information that provides useful 

insights on perceptions and opinions, 

but are not statistical surveys that yield 

quantitative results that can be 

generalized to the population of study. 

This collection of information is 

necessary to enable CBP to garner 

customer and stakeholder feedback in 

an efficient, timely manner, in 

accordance with our commitment to 

improving service delivery. The 

information collected from our 

customers and stakeholders will help 

ensure that users have an effective, 

efficient, and satisfying experience with 

CBP’s programs. This feedback will 

provide insights into customer or 

stakeholder perceptions, experiences 

and expectations, provide an early 

warning of issues with service, or focus 

attention on areas where 

communication, training or changes in 

operations might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative and 

actionable communications between 

CBP and its customers and stakeholders. 

It will also allow feedback to contribute 

directly to the improvement of program 

management. 

Type of Information Collection: 

Comment Cards. 


khammond on DSKJM1Z7X2PROD with NOTICES